Acute and subchronic toxicity of dimethylformamide and dimethylacetamide following various routes of administration

Drug and Chemical Toxicology
Gerald L Kennedy, H Sherman

Abstract

Dimethylformamide (DMF, CAS No. 68-12-2) and dimethylacetamide (DMAC, CAS No. 127-19-5) are widely used for their superior solvent properties. A series of single and multiple dose experiments in rodents were conducted to determine the target organs, and to establish doses which, under various routes of administration, produced those changes. DMF produced moderate irritation in the rabbit eye, with the corneal response clearing in 2 to 4 weeks. DMAC produced only mild, quickly reversible conjunctival irritation. Oral doses of DMF to the rat of 2,250 mg/kg or greater produced lethality which was associated with liver damage. Lethality occurred following oral doses of 4,500 mg/kg DMAC with LD50's for male and female rats of 5,809 and 4,930 mg/kg, respectively. The 1 hour LC50 by inhalation for DMAC in the rat was 2,475 ppm or greater. Sensory irritation was produced in the mouse at concentrations of 1,658 ppm or greater for DMF. Repeated oral doses of 450 mg DMF/kg to rats produced reduced body weight gain and liver injury with both changes being reversible. DMAC tested similarly produced body weight effects, liver injury, and testicular changes in the rat with all changes again being readily reversible. Dermal doses of 2,000 mg/k...Continue Reading

References

Mar 1, 1979·American Industrial Hygiene Association Journal·L E KaneY Alarie
Jan 1, 1976·Annual Review of Pharmacology and Toxicology·R P Smith, R E Gosselin
Jul 1, 1977·Toxicology and Applied Pharmacology·E F Stula, W C Krauss
Nov 1, 1973·CRC Critical Reviews in Toxicology·Y Alarie
Jan 1, 1961·Toxicology and Applied Pharmacology·H J HORN
Mar 1, 1963·American Industrial Hygiene Association Journal·J W CLAYTONG W SCHEPERS

❮ Previous
Next ❯

Citations

Nov 1, 2013·Pediatric Blood & Cancer·Kornelius KerlGeorg Hempel
Aug 23, 2006·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Anne-Magali LayreRuxandra Gref
May 27, 2006·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Doris OechteringGeorg Hempel
Feb 21, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·A LayreR Gref
Jan 11, 2002·Applied Occupational and Environmental Hygiene·C FinlayG L Kennedy
Sep 5, 2013·Chemical Society Reviews·Artur Ciesielski, Paolo Samorì
May 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Georg HempelJoachim Boos
May 16, 2017·Toxicological Sciences : an Official Journal of the Society of Toxicology·Zhijun WuJuan Cheng
Dec 17, 2003·Journal of Occupational Health·Hideki SenohTaijiro Matsushima
Apr 21, 2001·Bone Marrow Transplantation·Z HassanM Hassan
Jan 27, 2019·Chemistry, an Asian Journal·Kyriakos G Varnava, Vijayalekshmi Sarojini
Nov 7, 2019·QJM : Monthly Journal of the Association of Physicians·Jinglei Wang, Guiqian Chen
Jul 11, 2020·Journal of Applied Toxicology : JAT·Zhen ZhangQing Wang
Nov 30, 2019·International Journal of Toxicology·Melanie K BotheMartin Westphal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists
Philippe HantsonRobert Garnier
© 2021 Meta ULC. All rights reserved